False Positive Results in Newborn Hearing Screening

The purpose of this study is to investigate the rate of false-positive results in Newborn Universal Hearing Screening Programs and it´s possible causes.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Deafness Ear Diseases Hearing Disorders Hearing Loss Nervous System Diseases Neurologic Manifestations Otorhinolaryngologic Diseases Pathological Conditions, Signs and Symptoms Sensation Disorders Signs and Symptoms

Age range

6 hour–48 hour

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital Panamericano

Rio de Janeiro, 22.220-001, Brazil

About this study

False-positive results in Newborn Hearing Screening(NHS) leads to unnecessary parents anxiety and increase the cost of the procedure before hospital discharge. Getting to know the possible causes will lead to solutions to decrease the number of normal hearing babies that fail NHS with Otoacoustic Emissions.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Healthy newborns

Exclusion criteria

Risk factors for hearing loss

Treatment and study plan

Primary outcomes

Otoacoustic Emissions

Time frame: At birth

Sponsors and collaborators

Lead sponsor

Federal University of São Paulo

Other

Registry information

Official study title

False-Positive Results in Newborn Hearing Screening: Possible Causes

Acronym: NHS

Important dates

Study start: 2005
Primary completion: 2006
Study completion: 2007
First posted: Sep 16, 2008
Registry last updated: Sep 16, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed